New Pneumonia/Meningitis Vaccine Leads to First Canada-Cuba Joint Biotechnology Patent.: An article from: Canadian Chemical News

This digital document is an article from Canadian Chemical News, published by Chemical Institute of Canada on April 1, 2000. The length of the article is 400 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: New Pneumonia/Meningitis Vaccine Leads to First Canada-Cuba Joint Biotechnology Patent.
Publication:Canadian Chemical News (Magazine/Journal)
Date: April 1, 2000
Publisher: Chemical Institute of Canada
Volume: 52 Issue: 4 Page: 14

Distributed by Thomson Gale